Max Robotics — Global Service Robot Directory + US Certification

About

Chris Bangma is a leading researcher in urologic oncology, with a primary focus on advancing the diagnosis and treatment of prostate cancer. His work bridges cutting-edge radiation technology and surgical precision, most notably through pioneering studies on CyberKnife stereotactic radiotherapy as a monotherapy for low- to intermediate-stage prostate cancer. His 2010 paper on this topic, with 51 citations, demonstrated the feasibility and excellent tolerance of this approach, helping to establish hypofractionated stereotactic body radiotherapy as a viable, non-invasive treatment option. More recently, Bangma has turned his attention to improving surgical outcomes in robot-assisted radical prostatectomy. He has innovatively applied the video motion tracking software “Kinovea” to objectively assess surgical movements, a contribution detailed in a 2020 study (16 citations) that opens the door to more standardized surgical training and evaluation. Further extending this work, he has investigated how urethral stump measurements from surgical videos can predict postoperative urinary continence, directly impacting patient quality of life. Through these contributions, Bangma is shaping a future where prostate cancer care is both more effective and less debilitating.